Impact of depressive symptoms on the treatment of generalized social anxiety disorder

Depression and Anxiety

Volumn 22, Issue 4, 2005, Pages 161-167

  Ledley, Deborah Roth ^a   Huppert, Jonathan D ^a   Foa, Edna B ^a   Davidson, Jonathan R T ^b   Keefe, Francis J ^b   Potts, Nicholas L S ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cognitive therapy; Depression; Fluoxetine; Phobic disorders

Indexed keywords

FLUOXETINE; PLACEBO; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; EVIDENCE BASED MEDICINE; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON SCALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL PHOBIA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ANXIETY DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSION; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS;

EID: 30844435738     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20121     Document Type: Article

References (31)

1. Beck AT. 1967. Depression: Causes and treatments. Philadelphia: University of Pennsylvania Press.
2. Brown TA, Barlow DH. 1992. Comorbidity among anxiety disorders: Implications for treatment and DSM-IV. J Consult Clin Psychol 60:835-844.
3. Brown C, Schulberg HC, Madonia MJ. 1995. Assessing depression in primary care patients with the Beck Depression Inventory and the Hamilton Rating Scale for Depression. Psychol Assess 7:59-65.
4. Chambless DL, Tran GQ, Class CK. 1997. Predictors of response to cognitive-behavioral group therapy fur social phobia. J Anxiety Disord 11:221-240.
5. Clark DM, Ehlers A, McManus P, Hackmann A, Fennell M, Campbell H, Flower T, Davenport C, Louis B. 2003. Cognitive therapy vs fluoxetine in generalized social phobia: a randomized placebo controlled trial. J Consult Clin Psychol 71:1058-1067.
6. Davidson JRT, Foa FB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, Zhao N, Connor KM, Lynch, TR, Gadde, KM. 2004. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry 61:1005-1013.
7. Davidson JR, Hughes DL, George LK, Blazer DG. 1993. The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area study. Psychol Med 23:709-718.
8. Davidson JR, Potts N, Richichi E, Krishnan R, Ford SM, Smith R, Wilson WH. 1993. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 13:423-428.
9. Davidson JRT, Potts NLS, Richichi EA, Ford SM, Krishnan RR, Smith RD, Wilson W. 1991. The Brief Social Phobia Scale. J Clin Psychiatry 52:48-51.
10. Erwin BA, Heimberg RG, Juster H, Mindin M. 2002. Comorbid anxiety and mood disorders among persons with social anxiety disorder. Behav Res Ther 40:19-35.
11. Foa EB, Franklin ME, Moser J. 2002. Context in the clinic: How well do CBT and medications work in combination? Biol Psychiatry 52:987-997.
12. Franklin ME, Jaycox LH, Foa EB. 1999. Social skills training. In: Hersen M, Bellack A, editors. Handbook of comparative treatments for adult disorders. 2nd ed. New York: Wiley. p 317-339.
13. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff CB, Vittone BJ, Tancer ME, Bartko JJ. 1991. Cognitive-behavioral and pharmacological treatments for social phobia: a controlled study. Arch Gen Psychiatry 48:938-945.
14. Guy W. 1976. "ECDEU assessment manual for psychopharmacology." Washington, DC: Department of Health, Education and Welfare, Publication No. ADM 76-338. p 217-222.
15. Hamilton M. 1967. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
16. Heimberg RG, Dodge CS, Hope DA, Kennedy CR, Zollo L, Becker RE. 1990. Cognitive-behavioral group treatment of social phobia: comparison to a credible placebo control. Cogn Ther Res 14:1-23.
17. Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz L, Juster HR, Campens R, Bruch MA, Cloitre M, Fallon B, Klein DF. 1998. Cognitive-behavioral group therapy versus phenelzine in social phobia: 12-week outcome. Arch Gen Psychiatry 55:1133-1141.
18. Huppert JD, Roth DA, Foa EH. 2003a. Cognitive behavioral treatment of social phobia: new advances. Curr Psychiatry Rep 5:289-296.
19. Huppert JD, Franklin ME, Foa EB, Davidson JRT. 2003b. Study refusal and exclusion from a randomized treatment study of generalized social phobia. J Anxiety Disord 17:683-693.
20. Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW, Mantel JM, Serlin RC. 1995. Sertraline in social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 152:1368-1371.
21. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19.
22. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ. 2002. Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study. J Clin Psychopharmacol 22:257-262.
23. Lecrubier Y, Weiller E. 1997. Comorbidities in social phobia. Int Clin Psychopharmacol 12(Suppl 6):S17-S21.
24. Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer AJ. 1992. Phenelzine vs. atenolol in social phobia: a placebo-controlled comparison. Arch Gen Psychiatry 49:290-300.
25. Nelson EC, Grant JD, Bucholz, KK, Glowinski A, Madden PAF, Reich W, Heath AC. 2000. Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms. Psychol Med 30:797-804.
26. Noyes R, Moroz G, Davidson JRT, Liebowitz MR, Davidson A, Siegel J, Bell J, Cain J, Curlik SM, Kent T, Lydiard B, Mallinger A, Pollack M, Rapaport M, Rasmussen S, Reimherr F, Schweizer E, Uhlenhuth EH. 1997. Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol 17:247-254.
27. Schneier FR, Campeas R, Coplan J, Fallon BA, Hollander E, Liebowitz M, Saoud JB. 1993. Buspirone in social phobia. J Clin Psychopharmacol 13:251-256.
28. Stein MB, Chartier MJ, Hazen AL, Kroft CDL, Chale RA, Cote D, Walker JR. 1996. Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation. J Clin Psychopharmacol 16:218-222.
29. Stein MB, Fuetsch M, Muller N, Hofler M, Lieb R, Wittchen H-U. 2001. Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults. Arch Gen Psychiatry 58:251-256.
30. Stein MB, Kean YM. 2000. Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry 157:1606-1613.
31. Van Ameringen M, Mancini C, Styan G, Donison D. 1991. Relationship of social phobia with other psychiatric illness. J Affect Disord 21:93-99.